Chronic low-grade inflammation — sometimes called 'inflammaging' — underlies virtually every major chronic disease: cardiovascular disease, type 2 diabetes, Alzheimer's, arthritis, and many cancers. Measured by markers including C-reactive protein (CRP), IL-6, and TNF-alpha, chronic inflammation is now understood as a primary disease driver rather than a symptom. Multiple natural compounds have demonstrated significant anti-inflammatory effects in human RCTs — some with potency approaching pharmaceutical anti-inflammatories at therapeutic doses, with vastly superior safety profiles for long-term use.
Best Supplements for Inflammation
We assessed each supplement for clinical evidence quality, mechanism of action, dosing transparency, and safety. Evidence grades: A = strong RCT evidence; B = good clinical evidence; C = preliminary or emerging evidence.
The most comprehensively studied natural anti-inflammatory supplement. EPA and DHA inhibit NF-κB (master inflammation regulator), reduce prostaglandin E2 production, lower IL-6 and TNF-alpha, and raise anti-inflammatory resolvins and protectins. Meta-analyses consistently show significant CRP, IL-6, and TNF-alpha reductions at 2–4 g EPA+DHA/day. Most effective when omega-6:omega-3 ratio is also reduced through diet.
Curcumin inhibits NF-κB, COX-2, and multiple pro-inflammatory cytokines. Head-to-head RCTs show curcumin reduces joint pain and inflammation comparably to ibuprofen in knee osteoarthritis. The critical caveat: standard curcumin from turmeric powder has <1% bioavailability. Enhanced forms (Theracurmin, Meriva phytosome, BCM-95, or curcumin + piperine) are required for meaningful anti-inflammatory blood levels.
Targets a completely different inflammation pathway from omega-3 and curcumin — inhibiting 5-lipoxygenase (5-LOX) and leukotriene production. This complementary mechanism makes boswellia particularly valuable when combined with omega-3 (COX pathway) and curcumin (NF-κB). Multiple RCTs show significant joint pain reduction, and some studies show benefits in inflammatory bowel disease.
Magnesium deficiency directly promotes inflammatory signalling — NF-κB activation, elevated CRP, and increased pro-inflammatory cytokine production. Multiple epidemiological studies and RCTs show magnesium supplementation significantly reduces CRP, IL-6, and other inflammation markers. This is particularly relevant given that over 50% of people are magnesium-deficient.
Vitamin D functions as a steroid hormone that directly modulates immune cell activity and reduces pro-inflammatory cytokine production. Deficiency is strongly associated with elevated CRP and IL-6. Multiple RCTs show supplementation reduces inflammatory markers, particularly in deficient individuals. Anti-inflammatory effects complement bone and immune benefits.
Plant polyphenols with potent anti-inflammatory and antioxidant activity in vitro and animal models. Human RCT evidence is growing but still limited. Quercetin inhibits histamine release and LOX/COX pathways. Resveratrol activates SIRT1 and AMPK, reducing NF-κB activity. Both show CRP reductions in some human trials. Bioavailability concerns apply — liposomal forms may be superior.
⚠ Safety & Medical Disclaimer
High-dose omega-3 (>3 g/day) has antiplatelet effects — use caution with blood thinners. Curcumin inhibits CYP3A4 and may affect medication levels — consult your pharmacist. Boswellia may reduce warfarin effectiveness. Chronic inflammation requires medical assessment — do not use supplements as a substitute for investigating the underlying cause. CRP >10 mg/L indicates acute inflammation requiring medical evaluation.
Frequently Asked Questions
Clinical References
All supplement recommendations are supported by peer-reviewed research. Key citations:
- Calder PC. (2017). Biochem Soc Trans. Omega-3 fatty acids and inflammatory processes: from molecules to man. → Source
- Hewlings SJ & Kalman DS. (2017). Foods. Curcumin: a review of its effects on human health. → Source
- Sontakke S et al. (2007). Int J Pharm Sci Res. Comparative study of Boswellia serrata and celecoxib for osteoarthritis. → Source
- Simental-Mendía LE et al. (2017). Eur J Clin Invest. Effect of magnesium supplementation on plasma CRP concentrations. → Source